2027 ICD-10-CM Diagnosis Code D17.30Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites

ICD-10-CM Codes›C00–D49›D10-D36›D17

ICD-10-CM D17.30
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

D17.30 is a billable ICD-10-CM diagnosis code for benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 606 through 607. Coders also document this condition as chondroid lipoma. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Benign neoplasms.

Code Identity

ICD-10-CM Code
D17.30
Billable Status
Yes — Valid for Submission
Code Describes
Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites
Short Description
Benign lipomatous neoplasm of skin, subcu of unsp sites
Parent Code
D17.3
Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

Code Classification

ChapterC00–D49Neoplasms
SectionD10-D36Benign neoplasms, except benign neuroendocrine tumors
CategoryD17Benign lipomatous neoplasm
This CodeD17.30Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Chondroid lipoma
  • Deep subfascial lipoma
  • Lipoma of skin
  • Lipoma of skin and subcutaneous tissue
  • Subcutaneous lipoma

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to D17.30: its own notes plus those printed at Chapter 2. A note printed at a category, block or chapter applies to every code under it.

Notes

General instructions on how these codes are used.

From Chapter 2 (C00-D49) Neoplasms applies to 1,730 codes
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name D17.30, its category, or a range that includes it.

Excludes1 2

These codes carry an Excludes1 note naming D17.30: they are not reported together with it, unless the two conditions are unrelated.

  • D21 Other benign neoplasms of connective and other soft tissue
    lipomatous neoplasm (D17.-) names D17.-, which includes this code
  • D23 Other benign neoplasms of skin
    benign lipomatous neoplasms of skin (D17.0-D17.3) names D17.0-D17.3, which includes this code

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO073
Benign neoplasms
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Benign Lipomatous Neoplasm

    a mesenchymal neoplasm composed of adipose (fatty) tissue. there is no evidence of atypical or malignant cytological and architectural features, invasive features, or metastases.

Patient EducationClinical

Benign Tumors

Tumors are abnormal growths in your body. They can be either benign or malignant. Benign tumors aren't cancer. Malignant ones are. Benign tumors grow only in one place. They cannot spread or invade other parts of your body. Even so, they can be dangerous if they press on vital organs, such as your brain.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D17.30 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
214.1 Lipoma skin NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About D17.30Overview

Is D17.30 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does D17.30 group to?

When benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites is the principal diagnosis on an inpatient stay, it groups to MS-DRG 607, 606, with relative weights from 0.8772 to 1.5721 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D17.30?

Under the General Equivalence Mappings, benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites converts to ICD-9-CM 214.1 (lipoma skin NEC). The mapping is approximate, so confirm the match fits the documentation.